早期弥漫性系统性硬化症皮肤基因表达显示固有与适应性免疫炎症特征
该研究对48例早期弥漫性皮肤型系统性硬化症(SSc)患者(平均病程1.3年)及33名健康对照的皮肤活检RNA进行下一代测序,并与55例病程较长患者(平均7.4年)比较。结果显示早期患者皮肤中M2(96%)、M1(94%)巨噬细胞及CD8 T细胞(65%)、CD4 T细胞(60%)、B细胞(69%)特征高发,且免疫细胞特征与较短病程相关,而成纤维细胞和巨噬细胞特征与较高mRSS相关。
要点
- 早期弥漫性SSc皮肤中固有免疫(M1/M2巨噬细胞)和适应性免疫(T/B细胞)特征高发。
- 免疫细胞特征与较短病程相关,成纤维细胞和巨噬细胞特征与较高mRSS相关。
- 免疫细胞特征与活检前皮肤厚度进展率相关,但不能预测后续mRSS进展。
核心结论
- 早期弥漫性SSc皮肤具有突出的固有和适应性免疫细胞特征。
- 这些免疫特征反映了活检前的疾病进展速率,可能对理解发病机制和临床试验设计有启示。
研究设计与样本
- 对PRESS队列48例早期弥漫性SSc患者(平均病程1.3年)和33名匹配健康对照的皮肤活检RNA进行下一代RNA测序。
- 与Genetics versus Environment in Scleroderma Outcomes Study队列55例病程较长患者(平均7.4年)及匹配对照的类似数据进行比较。
- 分析细胞类型特异性特征,并评估与组织学特征和临床病程的相关性。
主要发现
- PRESS队列SSc患者中M2巨噬细胞特征占96%,M1巨噬细胞特征占94%,CD8 T细胞特征占65%,CD4 T细胞特征占60%,B细胞特征占69%。
- 免疫细胞标志物的免疫组化染色与基因表达基础的免疫细胞特征相关。
- 早期弥漫性SSc患者免疫细胞特征患病率高于病程较长患者。
- 多变量模型中,适应性免疫细胞特征与较短病程显著相关,成纤维细胞和巨噬细胞特征与较高mRSS相关。
- 免疫细胞特征与活检前皮肤厚度进展率相关,但不能预测后续mRSS进展。
临床怎么用
- 对于早期弥漫性皮肤型SSc患者,皮肤基因表达分析可揭示突出的免疫炎症特征,提示固有和适应性免疫参与早期发病。
- 免疫细胞特征与活检前疾病进展速率相关,可用于评估既往疾病活动度,但不用于预测后续皮肤厚度变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Determine global skin transcriptome patterns of early diffuse systemic sclerosis (SSc) and how they differ from later disease. METHODS: Skin biopsy RNA from 48 patients in the Prospective Registry for Early Systemic Sclerosis (PRESS) cohort (mean disease duration 1.3 years) and 33 matched healthy controls was examined by next-generation RNA sequencing. Data were analysed for cell type-specific signatures and compared with similarly obtained data from 55 previously biopsied patients in Genetics versus Environment in Scleroderma Outcomes Study cohort with longer disease duration (mean 7.4 years) and their matched controls. Correlations with histological features and clinical course were also evaluated. RESULTS: SSc patients in PRESS had a high prevalence of M2 (96%) and M1 (94%) macrophage and CD8 T cell (65%), CD4 T cell (60%) and B cell (69%) signatures. Immunohistochemical staining of immune cell markers correlated with the gene expression-based immune cell signatures. The prevalence of immune cell signatures in early diffuse SSc patients was higher than in patients with longer disease duration. In the multivariable model, adaptive immune cell signatures were significantly associated with shorter disease duration, while fibroblast and macrophage cell type signatures were associated with higher modified Rodnan Skin Score (mRSS). Immune cell signatures also correlated with skin thickness progression rate prior to biopsy, but did not predict subsequent mRSS progression. CONCLUSIONS: Skin in early diffuse SSc has prominent innate and adaptive immune cell signatures. As a prominently affected end organ, these signatures reflect the preceding rate of disease progression. These findings could have implications in understanding SSc pathogenesis and clinical trial design.
引用
- Skaug B, Khanna D, Swindell WR, et al. Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile. Ann Rheum Dis. 2019. PMID: 31767698. doi:10.1136/annrheumdis-2019-215894
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。